Transition From Buphenyl to RAVICTI for the Therapy of Byler Disease
- Conditions
- Byler Disease
- Registration Number
- NCT01949766
- Lead Sponsor
- University of Pittsburgh
- Brief Summary
This is a single patient compassionate use protocol to determine whether RAVICTI will improve bile flow in a subject who previously tolerated therapy with Buphenyl.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NO_LONGER_AVAILABLE
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- Byler Disease
- Cholestasis
- Tolerance of Buphenyl therapy
Read More
Exclusion Criteria
- Allergy/Hypersensitivity to RAVICTI
Read More
Study & Design
- Study Type
- EXPANDED_ACCESS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method